(A) Maximum percent decrease in FEV for each patient from postdose/pre-challenge after treatment with placebo (DB-placebo) or levalbuterol (DB-levalbuterol) during the double-blind... by D.S. Pearlman (92703)

Validation of AgRP neuron-specific <i>Girk1</i> and <i>Girk2</i> deletion. by Youjin Oh (3308670)

CoCl₂ induces CpG island demethylation and WT1 expression in primary AML samples. by Gregory McCarty (708081)

Subjects:

Exposure to IQ3A compounds decreases <i>HSP90</i> and <i>KRAS</i> mRNA, protein expression and <i>KRAS</i> transcription. by Hugo Brito (747224)

Contribution of GIRK2-containing channels to RMP and GABA_B-induced inhibition of NPY neurons. by Youjin Oh (3308670)

“…(B, C) Bar graphs and dots summarize RMP (−47.9 ± 0.9 mV, <i>n</i> = 64, for NPY^G2WT and −44.5 ± 0.7 mV, <i>n</i> = 41, for NPY^G2KO, df = 103, t = 2.556, <i>p</i> = 0.012) (B) and input resistance (2.35 ± 0.11 GΩ, <i>n</i> = 64, for NPY^G2WT and 2.78 ± 0.11 GΩ, <i>n</i> = 41, for NPY^G2KO, df = 103, t = 2.590, <i>p</i> = 0.011) (C) of NPY^G2WT (<i>n</i> = 64, black) and NPY^G2KO (<i>n</i> = 41, red) neurons. …”

hMDA-7 BSA-NPs decrease pancreatic tumor volumes in BXPC-3 and PANC-1 xenografts. by Qingyun Zhu (4497790)

Downregulation of DOM decreases the abundance of PER and TIM. by Zhenxing Liu (399809)

“…Downregulation of DOM decreased PER levels at CT1-5 and CT17-21. (Scale bar: 50 um.) …”

Inclusion of TPP side chains result in decreased melanoma cell mitochondria membrane potential, oxygen consumption, and increased DHE oxidation. by Kyle C. Kloepping (9928265)

“…<p>(A) A375 melanoma cells were treated with 0.5 μM, 1.0 μM, or 2.0 μM 5-, 10-, or 16-TPP for 1 h and analyzed for mitochondria membrane potential by the JC-1 method (* significant relative to control; p<0.05; n = 2 from 2 separate experiments; N = 4). …”

Additional behavioral patterns in the 5€, 100€, and 1000€ treatments. by Pablo Brañas-Garza (336425)

S1/2^-/- mice display novelty induced hyperactivity, decreased anxiety and exploratory behavior and working memory disturbances. by Paul C. Baier (650225)

“…WT: n = 24, S1/2^-/-: n = 26. A) Novelty-induced hyperactivity in S1/2^-/- mice as assessed by moving distance in the open field (p_MW = 0.0006). …”

Treatment by AG1024 induces unpairing of adult worms and decrease of egg laying in a dose and time-dependent manner. by Mathieu Vanderstraete (154327)

PGM1 enhances glycogen synthesis but inhibits aerobic glycolysis. by Guang-Zhi Jin (2178760)

PGM1 inhibits tumor cell proliferation and tumor growth. by Guang-Zhi Jin (2178760)

Loss of primary cilia and decreased nephron number in mice with Tamoxifen-induced <i>Kif3a</i> deficiency. by Lijun Chi (196000)

“…(D, E) The number of primary cilia (green) is markedly decreased in both SIX2-positive cells (nephrogenic precursors) and in ureteric cells <i>Kif3a™</i> kidney (E, asterisk) compared to WT kidney (D). …”

HDAC5 inhibitors reverse the decreased expression of GR induced by DEX in cultured prefrontal cortical astrocytes. by Shi-Ying Yuan (2937669)

WT1 mRNA and WT1 lncRNA are co-expressed from the same locus. by Gregory McCarty (708081)

Subjects:

METTL10 tri-methylates K318 in EF1A1. by Tadahiro Shimazu (619411)

Mutant channel with deletion of the S10 region has decreased surface expression in a stable HEK293 cell line. by Shumin Bian (191969)

“…Surface to total ratios were obtained by integration of the histograms. There is a 40% decrease in surface protein expression for the HSloΔS10 mutant determined by the surface to total HSlo ratio (+/− SEM, p = 0.032 in two sample t-test .n = 5).…”

MCU is required for normal presynaptic Ca²⁺ clearance and MCU expression is decreased in LKB1-null hippocampi. by Seok-Kyu Kwon (3151941)

VEGFR2/VEGF-A ligand binding decreased ranibizumab and aflibercept mediated CCL2, CCL5, and CX3CL1 mRNA and protein levels in HCAECs. by Clare Arnott (2557705)